Creative Medical Technology Holdings, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Phoenix, AZ
CELZ chart
What traders are saying about $CELZ
Latest postsCreative Medical Technology Holdings, Inc. news
- Creative Medical Technology Holdings, Inc. Estimates – NASDAQ:CELZ
TradingView ·
- Creative Medical Technology Holdings, Inc. (CELZ) interactive stock chart – Yahoo Finance
Yahoo Finance Singapore ·
- Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis Study
Yahoo Finance ·
- Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
Yahoo Finance ·
- Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
Yahoo Finance ·
- Creative Medical Receives U.S. Patent Allowance for Exosome-Based Type 1 Diabetes Immunotherapy
investorshub.advfn.com ·
- Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms
Yahoo Finance ·
- Creative Medical Technology Holdings Issues Mid-Year Update
Yahoo Finance ·
- Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
Yahoo Finance ·
- These Three Stocks Fell More Than 10% Today To Hit 52-Week Lows -- What's Driving The Investor Skepticism?
stocktwits.com ·
- Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
Yahoo Finance ·
- Creative Medical Technology opens nationwide burn-pit data registry
proactiveinvestors.com ·
Creative Medical Technology Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $6,000 | $11,000 | $9,000 | $88,600 |
| Net income | -$6.0M | -$5.5M | -$5.3M | -$10.1M |
| Diluted EPS | $-2.52 | $-3.71 | $-3.76 | $-0.93 |
| Total assets (year end) | $7.8M | $6.7M | $10.7M | $19.2M |
| Cash and equivalents (year end) | – | – | – | $8.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Creative Medical Technology Holdings, Inc.
- Ticker
- CELZ (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Phoenix, AZ
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1187953
- Former names
- JOLLEY MARKETING INC
Frequently asked questions
What exchange is Creative Medical Technology Holdings, Inc. listed on?
Creative Medical Technology Holdings, Inc. trades on the Nasdaq under the ticker symbol CELZ.
What industry is Creative Medical Technology Holdings, Inc. in?
Creative Medical Technology Holdings, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Creative Medical Technology Holdings, Inc. headquartered?
Creative Medical Technology Holdings, Inc.'s business address on file with the SEC is in Phoenix, AZ.
When does Creative Medical Technology Holdings, Inc.'s fiscal year end?
Creative Medical Technology Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Creative Medical Technology Holdings, Inc. report?
Creative Medical Technology Holdings, Inc. reported $6,000 in revenue for calendar year 2025, according to its SEC filings.